Safety & Candidacy This peptide combination leverages well-researched mechanisms: Tesamorelin (FDA-approved for lipodystrophy), Ipamorelin (extensively studied for GH release), and MOTS-c (emerging mitochondrial peptide with metabolic research)
However, the clinical significance of TMAO generation from L-carnitine supplementation in humans remains under active investigation, and there is currently no official regulatory warning from the MHRA or EMA specifically prohibiting its use on these grounds
[DOI] [PubMed] [Google Scholar] Sakai Y., Nishikawa H., Enomoto H., Yoh K., Iwata Y., Hasegawa K., Nakano C., Kishino K., Shimono Y., Takata R., Nishimura T., Aizawa N., Ikeda N., Takashima T., Ishii A., Iijima H., Nishiguchi S
(2003) A short history of nutritional science: Part 3 (1912-1944)
B12 deficiency in particular can cause megaloblastic anemia